NCT02724670Recruiting
Study of MR-based IGRT for Prostate Cancer
Single-arm Phase II Study of MR(Magnetic Resonance Imaging)-Based Image-guided Radiotherapy for Prostate Cancer
Source: ClinicalTrials.gov · Last updated 25 Sept 2019 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 78 (estimated)
- First submitted
- 10 Mar 2016
- Start date
- 1 Mar 2016
- Primary completion date
- 30 Jun 2020
- Lead sponsor
- University Hospital Tuebingen
- Diseases
- Prostate cancer
- NCT number
- NCT02724670
What you commit to
- Study type: Interventional
- Planned participants: 78
- From 1 Mar 2016 to the primary completion date, 30 Jun 2020
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous pelvic radiotherapy or prostatic treatment like TURP (transurethral resection of prostate), HIFU (high intensity focused ultrasound)
- serious comorbidity leading to inability for IGRT (image-guided radiotherapy)
Age
- age\<18year
Other
- contraindications for curative treatment
- contraindications for MRI (Magnetic Resonance Imaging)
Who the study is looking for
- histologically proven prostate cancer
- indication for curative treatment
- ECOG performance scale 0-2
- Informed consent
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Müller Arndt-Christian Coordinator of this site? Confirm its status | Tübingen | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.